Friday 6 November 2026 Export DGX’s income statement to Excel — free account

Quest Diagnostics Incorporated

Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024.

Revenue: +9.98%
EPS: +29.4%
Free cash flow: +6.21%
Total debt: −2.20%

Quarter to September 2026, against a year earlier

255.90 1.16 +0.46%

Follow DGX

Alert me

Market cap: $28.0B
P/E: 25.1×
Fwd P/E: 24.4×
Dividend yield: 1.32%
F-score: 8/9
Altman Z: 3.15
Beneish M: −2.65
Dividend safety: 85/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Quest Diagnostics Incorporated (DGX) P/E ratio

Alert me on P/E ratio

As of 6 November 2026, Quest Diagnostics Incorporated (DGX) trades at a P/E ratio of 25.1×. Over the past ten years it has ranged from 7.7× (June 2021) to 25.9× (September 2026); the current reading is higher than 99% of that period. That is below the Diagnostics & Research industry median of 35.2× and in line with the Healthcare sector median of 24.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/DGX/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Quest Diagnostics Incorporated P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/DGX/metrics/pe-ratio">Quest Diagnostics Incorporated (DGX) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	19.6×	0.89%
FY2024	19.4×	4.51%
FY2023	18.6×	(4.00%)
FY2022	19.3×	77.28%
FY2021	10.9×	(3.03%)
FY2020	11.2×	(33.04%)
FY2019	16.8×	8.69%
FY2018	15.4×	(12.05%)
FY2017	17.6×	(13.16%)
FY2016	20.2×	39.91%

Period	P/E ratio	Change
Sep 2026	22.9×	3.05%
Jun 2026	22.2×	3.95%
Mar 2026	21.4×	9.24%
Dec 2025	19.6×	(11.31%)
43 more quarters	Free account

Against its own ten years

Low 7.7× High 25.9×

Ten-year median 18.6×

Current reading's percentile 99

Company	P/E ratio
GH Guardant Health, Inc. compare	n/m
DGX Quest Diagnostics Incorporated	25.1×
LH Labcorp Holdings Inc. compare	29.8×
IQV IQVIA Holdings Inc. compare	32.6×
MEDP Medpace Holdings, Inc. compare	35.5×
ILMN Illumina, Inc. compare	36.2×
MTD Mettler-Toledo International, Inc. compare	37.2×
RVTY Revvity Inc. compare	73.9×
WAT Waters Corporation compare	195×
Diagnostics & Research industry median	35.2×
Healthcare sector median	24.5×
Market median	17.8×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Quest Diagnostics Incorporated (DGX) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on DGX

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on DGX

Stockrow Weekly